ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium.
There is strong epidemiologic evidence indicating that common genetic variability could be implicated in pancreatic cancer risk and, to date, various loci have been proposed. In particular, there is increasing evidence of the involvement of ABO gene variability an...
Main Authors: | Rizzato, C, Campa, D, Pezzilli, R, Soucek, P, Greenhalf, W, Capurso, G, Talar-Wojnarowska, R, Heller, A, Jamroziak, K, Khaw, K, Key, T, Bambi, F, Landi, S, Mohelnikova-Duchonova, B, Vodickova, L, Büchler, M, Bugert, P, Vodicka, P, Neoptolemos, J, Werner, J, Hoheisel, J, Bauer, A, Giese, N, Canzian, F |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2013
|
Registos relacionados
-
Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium.
Por: Campa, D, et al.
Publicado em: (2013) -
Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation.
Por: Campa, D, et al.
Publicado em: (2017) -
Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study
Por: Campa, D, et al.
Publicado em: (2018) -
Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations.
Por: Campa, D, et al.
Publicado em: (2013) -
Genetic determinants of telomere length and risk of pancreatic cancer: a PANDoRA study
Por: Campa, D, et al.
Publicado em: (2017)